BamSEC and AlphaSense Join Forces
Learn More

Aktis Oncology Inc. – Material Contracts

NASDAQ: AKTS    
Share price (10/7/26): $18.00    
Market cap (10/7/26): $1.001 billion
Search in Documents
Key Exhibits
External Links

Material Contracts Filter

EX-10.18
from 10-K 8 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Second Amendment to Lease
12/34/56
EX-10.3
from S-8 19 pages Aktis Oncology, Inc. Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-8 39 pages Aktis Oncology, Inc. 2026 Equity Incentive Plan
12/34/56
EX-10.12
from S-1/A 19 pages Employment Agreement
12/34/56
EX-10.11
from S-1/A 19 pages Employment Agreement
12/34/56
EX-10.10
from S-1/A 20 pages Employment Agreement
12/34/56
EX-10.9
from S-1/A 19 pages Employment Agreement
12/34/56
EX-10.8
from S-1/A 19 pages Employment Agreement
12/34/56
EX-10.7
from S-1/A 20 pages Employment Agreement
12/34/56
EX-10.5
from S-1/A 2 pages Aktis Oncology, Inc. Non-Employee Director Compensation Policy
12/34/56
EX-10.3
from S-1/A 19 pages Aktis Oncology, Inc. Employee Stock Purchase Plan
12/34/56
EX-10.2
from S-1/A 39 pages Aktis Oncology, Inc. 2026 Equity Incentive Plan
12/34/56
EX-10.15
from S-1 7 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. First Amendment to Lease
12/34/56
EX-10.14
from S-1 62 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Lease Idb 17-19 Drydock Limited Partnership, a Delaware Limited Partnership Landlord and Aktis Oncology, Inc., a Delaware Corporation Tenant for the Innovation and Design Building Premises Located on the Fourth (4th) Floor of One Design Center Place Boston, Massachusetts January 13, 2022
12/34/56
EX-10.13
from S-1 5 pages Royalty Transfer Agreement
12/34/56
EX-10.12
from S-1 25 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. Exclusive License Agreement
12/34/56
EX-10.11
from S-1 87 pages Certain Information Contained in This Exhibit, Marked by [***], Has Been Excluded From This Exhibit Because the Registrant Has Determined That It Is Both Not Material and Is the Type That the Registrant Treats as Private or Confidential. License, Research and Collaboration Agreement Between Eli Lilly and Company and Aktis Oncology, Inc
12/34/56
EX-10.6
from S-1 17 pages Indemnification Agreement
12/34/56
EX-10.4
from S-1 3 pages Aktis Oncology, Inc. Senior Executive Cash Incentive Bonus Plan
12/34/56
EX-10.1
from S-1 31 pages Aktis Oncology, Inc. (Formerly Hotknot Therapeutics, Inc.) 2020 Equity Incentive Plan
12/34/56